Clinical trial
Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy…
NCT00331058 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00331058 |
|---|---|
| Title | Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects |
| Official title | A Study To Validate Key Therapeutic Targets and Characterise Their Response to Corticosteroids in Multiple Asthma Phenotypes |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Procedure |
| Interventions | Bronchoscopsy, Prednisolone |
| Enrollment | 58 |
| Start date | Feb 18, 2006 |
| Primary completion | Jul 7, 2011 |
| Completion | Jul 7, 2011 |
| First posted | May 29, 2006 |
| Last update posted | Jun 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: